These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12453746)

  • 1. Venlafaxine for major depression.
    Cipriani A; Geddes JR; Barbui C
    BMJ; 2007 Feb; 334(7587):215-6. PubMed ID: 17272528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The review by Weinmann and colleagues.
    Freemantle N
    Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
    Hunter AM; Leuchter AF; Morgan ML; Cook IA
    Am J Psychiatry; 2006 Aug; 163(8):1426-32. PubMed ID: 16877657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain tells: early signs of depression recovery.
    Harv Ment Health Lett; 2002 Nov; 19(5):6. PubMed ID: 12453746
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual action antidepressants and some important considerations.
    Gupta RK; Tiller JW; Burrows GD
    Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants.
    Frazer A
    J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract]   [Full Text] [Related]  

  • 11. New antidepressants for older people: a critical review of the evidence base.
    Katona C
    Encephale; 2008 Apr; 34 Suppl 2():S71-S76. PubMed ID: 18675006
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine: a 2003 update.
    Gutierrez MA; Stimmel GL; Aiso JY
    Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.